Digital neuro biomarkers market to be valued at 4.59b by 2032

Developments in wearable technology serve as a key driver.

The digital neuro biomarkers market is projected to reach $4.59b by 2032 at a compound annual growth rate of 25.96%, according to SNS Insider.

The sector’s expansion is attributed to the rising prevalence of neurological disorders, developments in wearable technology, and the integration of artificial intelligence in diagnostics.

“Diverse digital neuro biomarkers based on wearable, mobile apps and AI algorithms are revolutionizing the early detection, diagnosis, and monitoring of these conditions,” the report said.

Moreover, governments and healthcare organisations are increasingly investing in digital technologies to meet the growing need for precision medicine and personalised care.